2nd Quarter - Report

ALKERMES, INC. for ALKERMES, INC.

Period 2nd Quarter 2014 Filed Jul 18, 2014 Signed by Peter Norman, Vice President, Policy and Government Relations

Official filing
Firm
ALKERMES, INC.
Client
ALKERMES, INC.
Income
—
Expenses
$553,600
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Discuss need for educational resources and the use of Vivitrol for public health

LobbyistCovered position, as disclosed
ROBERT FORMAN —
PETER NORMAN —

Contacted: Justice, Dept of (DOJ); Office of Natl Drug Control Policy (NDCP); Natl Institute on Alcohol Abuse & Alcoholism (NIAA); SENATE; HOUSE OF REPRESENTATIVES; Natl Institutes of Health (NIH)

Alcohol and Drug Abuse ALC

Advance the use of FDA-approved medicines to treat addiction in criminal justice settings H.R.3465/S.1690, The Second Chance Act of 2013 - use of FDA-approved medicines in criminal justice settings S.1675, Recidivism Reduction and Public Safety Act of 2013 - use of FDA-approved medicines in criminal justice settings

LobbyistCovered position, as disclosed
ROBERT FORMAN —
PETER NORMAN —

Contacted: Natl Institute on Alcohol Abuse & Alcoholism (NIAA); SENATE; Natl Institutes of Health (NIH); HOUSE OF REPRESENTATIVES; Justice, Dept of (DOJ); Office of Natl Drug Control Policy (NDCP)

Bills named: H.R. 3465 (113th), S. 1675 (113th), S. 1690 (113th)

Medicare/Medicaid MMM

Maintain the program's six protected classes with respect to depression and schizophrenia

LobbyistCovered position, as disclosed
ROBERT FORMAN —
PETER NORMAN —

Contacted: Office of Natl Drug Control Policy (NDCP); Natl Institutes of Health (NIH); Justice, Dept of (DOJ); SENATE; Natl Institute on Alcohol Abuse & Alcoholism (NIAA); HOUSE OF REPRESENTATIVES

Pharmacy PHA

DEA regulatory transparency in controlled substances scheduling person DEA regulatory transparency in issuing research licenses and quotas

LobbyistCovered position, as disclosed
ROBERT FORMAN —
PETER NORMAN —

Contacted: HOUSE OF REPRESENTATIVES; Natl Institute on Alcohol Abuse & Alcoholism (NIAA); Office of Natl Drug Control Policy (NDCP); SENATE; Natl Institutes of Health (NIH); Justice, Dept of (DOJ)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.